Answers are grounded in this paper and cite their sources.
Assesses antibacterial efficacy of Siddha medicines in combating AMR, suggesting their therapeutic potential.
Background: The rise in AMR has intensified the search for alternative therapies, including those derived from the traditional systems of medicine. Several plant-based compositions known for their antibacterial qualities are used in Siddha, one of the oldest traditional medical systems still in use in South India. Aim and Objectives: This study aims to assess the antibacterial potential of four Siddha preparations (Nilavembu Kudineer, Thippili Rasayanam, Kandankathiri Kudineer, and Karpoora Chooranam) against clinically important bacterial strains. Materials and Methods: Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae are clinically significant bacterial strains that are tested for antibacterial efficacy in this study using four widely used Siddha preparations: Thippili Rasayanam, Nilavembu Kudineer, Kandankathiri Kudineer, and Karpoora Chooranam. Each of the four formulations was tested for antibacterial activity using the agar well-diffusion method. Results: The findings show that several Siddha formulations have strong antibacterial properties, with Nilavembu Kudineer showing the largest zone of inhibition against E. coli and S. aureus . Conclusion: These findings underscore the potential of Siddha medicines as alternative or complementary antimicrobial agents.
No takes yet. Share an insight, caveat, or question.
Akilan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: